Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $2.4 million.

  • Biofrontera's Other Operating Expenses fell 5151.7% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year decrease of 2049.16%. This contributed to the annual value of $36.2 million for FY2024, which is 528.78% down from last year.
  • Per Biofrontera's latest filing, its Other Operating Expenses stood at $2.4 million for Q3 2025, which was down 5151.7% from $2.7 million recorded in Q2 2025.
  • Biofrontera's 5-year Other Operating Expenses high stood at $25.8 million for Q4 2023, and its period low was $196000.0 during Q3 2022.
  • Over the past 5 years, Biofrontera's median Other Operating Expenses value was $3.8 million (recorded in 2021), while the average stood at $5.6 million.
  • As far as peak fluctuations go, Biofrontera's Other Operating Expenses crashed by 9377.78% in 2022, and later surged by 238163.27% in 2023.
  • Over the past 5 years, Biofrontera's Other Operating Expenses (Quarter) stood at $1.8 million in 2021, then soared by 206.86% to $5.7 million in 2022, then skyrocketed by 354.69% to $25.8 million in 2023, then dropped by 11.68% to $22.8 million in 2024, then plummeted by 89.63% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.7 million for Q2 2025, and $3.3 million during Q1 2025.